Brief: Landos Biopharma Reports Fourth Quarter And Full Year 2021 Results
24/03/2022 20:56
March 24 (Reuters) - Landos Biopharma Inc LABP.O :
* LANDOS BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2021
RESULTS AND PROVIDES BUSINESS UPDATE
* LANDOS BIOPHARMA INC - ON TRACK TO INITIATE PHASE 2B STUDY
OF
OMILANCOR IN ULCERATIVE COLITIS LATER THIS YEAR
Source text for Eikon: ID:nGNX44N7k7
Further company coverage: LABP.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Landos Biopharma
See all newsLandos Biopharma Inc expected to post a loss of 100 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Super Micro, Micron Technology, Navios Maritime
U.S. STOCKS ON THE MOVE-Landos Biopharma, Foot Locker, US energy sector
Brief: AbbVie To Acquire Landos Biopharma